Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity

Virology

Volumn 239, Issue 2, 1997, Pages 327-339

  Zhou, Jie ^b   Dutch, Rebecca Ellis ^a   Lamb, Robert A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE LIPID; VIRUS FUSION PROTEIN;

ARTICLE; CELL LABELING; CONFOCAL MICROSCOPY; CROSS LINKING; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; OLIGOMERIZATION; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SITE DIRECTED MUTAGENESIS; VIRUS MUTATION;

PARAMYXOVIRIDAE; RNA VIRUSES; SIMIAE; SIMIAN PARAINFLUENZA VIRUS 5; SIMIAN VIRUS;

EID: 0031583818     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8917     Document Type: Article

References (59)

1. Asano K., Asano A. Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes? Biochem. Int. 10:1985;115-122.
2. Bagai S., Lamb R. A. Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein. Virology. 209:1995a;250-256.
3. Bagai S., Lamb R. A. Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69:1995b;6712-6719.
4. Bagai S., Lamb R. A. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J. Cell Biol. 135:1996;73-84.
5. Bagai S., Lamb R. A. A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion. Virology. 1997.
6. Brand C. M., Skehel J. J. Crystalline antigen from the influenza virus envelope. Nature. 238:1972;145-147.
7. Buckland R., Malvoisin E., Beauverger P., Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1992;1703-1707.
8. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
9. Caras I., Weddell G., Davitz M., Nussenzweig V., Martin D. W. Signal for attachment of a phospholipid membrane anchor in decay accelerating factor. Science. 238:1987;1280-1283.
10. Cattaneo R., Rose J. K. Cell fusion by the envelope glycoproteins of persistent measles viruses which cause lethal human brain disease. J. Virol. 67:1993;1493-1502.
11. Chan D. C., Fass D., Berger J. M., Kim P. S. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:1997;263-273.
12. Crise B., Ruusala A., Zagouras P., Shaw A., Rose J. K. Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein. J. Virol. 63:1989;5328-5333.
13. Danieli T., Pelletier S. L., Henis Y. I., White J. M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell Biol. 133:1996;559-569.
14. Deng W. P., Nickoloff J. A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200:1992;81-88.
15. Ebata S. N., Cote M. J., Kang C. Y., Dimock K. The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology. 183:1991;437-441.
16. 7. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
17. Gething M.-J., McCammon K., Sambrook F. Protein folding and intracellular transport. Evaluation of conformational changes in nascent exocytotic proteins. Methods Cell Biol. 32:1989;185-206.
18. Gilbert J. M., Hernandez L. D., Chernov-Rogan T., White J. M. Generation of a water-soluble oligomeric ectodomain of the Rous sarcoma virus envelope glycoprotein. J. Virol. 67:1993;6889-6892.
19. Hiebert S. W., Paterson R. G., Lamb R. A. Hemagglutinin-neuraminidase protein of the paramyxovirus simian virus 5: Nucleotide sequence of the mRNA predicts an N-terminal membrane anchor. J. Virol. 54:1985;1-6.
20. Horvath C. M., Lamb R. A. Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: Roles of conserved residues in cell fusion. J. Virol. 66:1992;2443-2455.
21. Horvath C. M., Paterson R. G., Shaughnessy M. A., Wood R., Lamb R. A. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia. J. Virol. 66:1992;4564-4569.
22. Hu X., Ray R., Compans R. W. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J. Virol. 66:1992;1528-1534.
23. Kemble G. W., Henis Y. I., White J. M. GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity. J. Cell Biol. 122:1993;1253-1265.
24. Klenk H.-D., Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2:1994;39-43.
25. Lamb R. A. Paramyxovirus fusion: A hypothesis for change. Virology. 197:1993;1-11.
26. Lamb R. A., Choppin P. W. Synthesis of influenza virus proteins in infected cells: Translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology. 74:1976;504-519.
27. Lamb R. A., Etkind P. R., Choppin P. W. Evidence for a ninth influenza viral polypeptide. Virology. 91:1978;60-78.
28. Lamb R. A., Kolakofsky D. Paramyxoviridae: Virology. 1996;Raven Press, New York. p. 1177-1204.
29. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Bucy T., Erickson J., Merutka G., Perreway S. R. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA. 93:1996;2186-2191.
30. Moran P., Raab H., Kohr W. J., Caras I. W. Glycophospholipid membrane anchor attachment. Molecular analysis of the cleavage/attachment site. J. Biol. Chem. 266:1991;1250-1257.
31. Morris S. J., Sarkar D. P., White J. M., Blumenthal R. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. J. Biol. Chem. 264:1989;3972-3978.
32. Morrison T., Portner A. Structure, function, and intracellular processing of the glycoproteins ofParamyxoviridae. Kingsbury D. W. The Paramyxoviruses. 1991;347-382 Plenum Press, New York.
33. Morrison T. G., Ward L. J., Semerjian A. Intracellular processing of the Newcastle disease virus fusion glycoprotein. J. Virol. 53:1985;851-857.
34. Ng D. T., Randall R. E., Lamb R. A. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: Specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface. J. Cell Biol. 109:1989;3273-3289.
35. Novick S. L., Hoekstra D. Membrane penetration of Sendai virus glycoproteins during the early stage of fusion with liposomes as determined by hydrophobic affinity labeling. Proc. Natl. Acad. Sci. USA. 85:1988;7433-7437.
36. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
37. Paterson R. G., Harris T. J. R., Lamb R. A. Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology. 138:1984a;310-323.
38. Paterson R. G., Harris T. J. R., Lamb R. A. Fusion protein of the paramyxovirus simian virus 5: Nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc. Natl. Acad. Sci. USA. 81:1984b;6706-6710.
39. Paterson R. G., Hiebert S. W., Lamb R. A. Expression at the cell surface of biologically active fusion and hemagglutinin-neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc. Natl. Acad. Sci. USA. 82:1985;7520-7524.
40. Paterson R. G., Lamb R. A. Ability of the hydrophobic fusion-related external domain of a paramyxovirus F protein to act as a membrane anchor. Cell. 48:1987;441-452.
41. Paterson R. G., Lamb R. A. The molecular biology of influenza viruses and paramyxoviruses. Davidson A., Elliott R. M. Molecular Virology: A Practical Approach. 1993;35-73 IRL Oxford Univ. Press, Oxford.
42. Randall R. E., Young D. F., Goswami K. K. A., Russell W. C. Isolation and characterization of monoclonal antibodies to simian virus 5 and their use in revealing antigenic differences between human, canine and simian isolates. J. Gen. Virol. 68:1987;2769-2780.
43. Rapaport D., Ovadia M., Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses. EMBO J. 14:1995;5524-5531.
44. Reitter J. N., Sergel T., Morrison T. G. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:1995;5995-6004.
45. Rose J. K., Buonocore L., Whitt M. A. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. Biotechnology. 10:1991;520-525.
46. Russell R., Paterson R. G., Lamb R. A. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology. 199:1994;160-168.
47. Salzwedel K., Johnston P. B., Roberts S. J., Dubay J. W., Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 67:1993;5279-5288.
48. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
49. Scheid A., Caliguiri L. A., Compans R. W., Choppin P. W. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology. 50:1972;640-652.
50. Sergel-German T., McQuain C., Morrison T. Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:1994;7654-7658.
51. Sheshberadaran H., Lamb R. A. Simian virus 5 membrane protein maturation: Expression in virus-infected cells and from a eukaryotic vector. Virology. 183:1991;803-809.
52. Skehel J. J., Bayley P. M., Brown E. B., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. Changes in the conformation of the influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA. 79:1982;968-972.
53. Tanabayashi K., Takeuchi K., Okazaki K., Hishiyama M., Yamada A. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: Both F and HN proteins are required for cell fusion. Virology. 187:1992;801-804.
54. Walter E. I., Roberts W. L., Rosenberry W. D., Ratnoff W. D., Medof W. D. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage. J. Immunol. 144:1990;1030-1036.
55. Ward C. D., Paterson R. G., Lamb R. A. Mutants of the paramyxovirus SV5 fusion protein: Regulated and extensive syncytium formation. Virology. 209:1995;242-249.
56. Weissenhorn W., Dessen A., Harrison S. C., Skehel J. J., Wiley D. C. Atomic structure of the ectodomain from HIV-1 gp41. Nature. 387:1997;426-430.
57. Wild T. F., Malvoisin E., Buckland R. Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72:1991;439-442.
58. Wilson I. A., Skehel J. J., Wiley D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature. 289:1981;366-375.
59. Yao Q., Compans R. W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology. 223:1996;103-112.